Seprafilm in Open Abdomens: a Study of Wound and Adhesion Characteristics in Trauma Damage Control Patients
Completed · Not applicable
Conditions studied: Open Abdomen, Abdominal Adhesions, Trauma, Wounds and Injury
In brief
The goal of this study is to test the effects of Seprafilm adhesion barrier on patients who are undergoing open abdomen damage control management for traumatic injuries when compared to no adhesion barrier use. Specifically, the researchers wish to study the effects of Seprafilm adhesion barrier on: * the number and intensity of adhesions, * whether there is any difference between treatment groups (Seprafilm vs. no Seprafilm) who go on to successful definitive abdominal closure, * rate of occurrence of secondary complications (such as abscesses) associated with short- and long-term beneficial effects of reducing adhesion formation,and * whether there is any difference between treatment groups regarding patient functional recovery.
Key facts
- Study ID
- NCT01594385
- Run by
- Stan Stawicki
- People needed
- 30
- Starts
- 2010-04-01
- Expected to finish
- 2013-12-01
- Last updated by the study team
- 2017-11-20
Who can join
Age: 18 and older, up to 89. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Trauma patients undergoing DC/OA management for traumatic injury
- Age 18+
- Life expectancy longer than 48 hours
You may not qualify if…
- Prisoners
- Pregnant patients
- Younger than 18 years of age
Where it is running
- Cooper University Hospital — Camden, New Jersey, United States
- Carolinas Medical Center — Charlotte, North Carolina, United States
- The Ohio State University Medical Center — Columbus, Ohio, United States
- St. Luke's Hospital — Bethlehem, Pennsylvania, United States
- Thomas Jefferson University — Philadelphia, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.